PATENT CLAIM ANALYSIS

Application Number: 16119962
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["544", "387000"]

Abstract:
The present invention relates to compounds and compositions for inhibition of FASN, their synthesis, applications, and antidotes.

Claim (Index 2):
The compound of  claim 1 , wherein\n (a) A and B are O; (b) R 1  is a 3 or 4 membered cycloalkyl or heterocycloalkyl wherein (i) the heteroatom ring member of the 3 or 4 membered heterocycloalkyl is independently selected from O, S, or N, and (ii) each of said 3 or 4 membered cycloalkyl or heterocycloalkyl is either unsubstituted or optionally substituted with substituents selected from the group consisting of \u2014R a , \u2014OR a , \u2014NHR a , and \u2014NR a R a1 ; and (c) L is a 6 member monocyclic substituted heteroalkyl wherein the heteroatom ring members are independently selected from O, S, or N.

Metadata:
- Claim Count in Document: 147.0
- Percentile: 96.0
- Lexical Diversity: 1.16667
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15786539', '15905524', '14451600', '14774937', '14631625']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8393016898086398
- 35 USC 102 Novelty (BERT): 0.5853644972313248
- Combined Prediction Score: 0.8139079705509084
- Mean Citation Score: 397.345142
- Max Citation Score: 544.4386599999998
- Similarity Product: 427.541165962876

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test